GIN4 antibodies are polyclonal reagents raised against specific regions of the Gin4 protein, a member of the Nim1 kinase family. Gin4 is essential for septin assembly, mitotic control, and proper daughter cell growth during the G2/M phase . These antibodies are primarily used in molecular and cellular biology to:
GIN4 antibodies are generated using recombinant fragments of the Gin4 protein. Key methods include:
Immunogen Design: A COOH-terminal fragment (residues 936 to stop codon) or a 6X-histidine-tagged fusion protein is used for immunization .
Antibody Purification: Affinity purification with maltose-binding protein (MBP) or glutathione S-transferase (GST) fusion proteins ensures specificity .
Validation: Specificity is confirmed via Western blotting in wild-type versus gin4Δ strains .
Gin4 antibodies revealed that Gin4 is required for septin localization at the bud neck. In gin4Δ mutants, septins fail to form organized rings, leading to aberrant cell morphology .
Co-immunoprecipitation studies using GIN4 antibodies identified a mitotic complex containing Gin4, Nap1, Bni5, and septins. This complex facilitates Gin4 hyperphosphorylation and activation during mitosis .
Gin4 antibodies helped demonstrate that the nucleolus-associating domain of Gin4 binds Cdc14, a phosphatase critical for mitotic exit. Deletion of this domain causes premature exit from mitosis .
GIN4 antibodies are pivotal in studying:
Cell Cycle Checkpoints: Gin4’s role in the G2/M transition .
Septin Dynamics: How septins coordinate cytokinesis and cell polarity .
Protein Kinase Networks: Cross-talk between Gin4, Nap1, and other regulatory kinases .
KEGG: sce:YDR507C
STRING: 4932.YDR507C
GIN4 is a Nim1-related kinase in budding yeast that plays a critical role in septin localization and proper control of daughter cell growth during G2/M phase. The protein becomes hyperphosphorylated when cells enter mitosis, leading to activation of its kinase activity . GIN4 antibodies are important research tools because they allow for the detection, isolation, and characterization of GIN4 and its interaction partners. These antibodies enable researchers to investigate GIN4's role in cell cycle regulation, septin organization, and mitotic progression through techniques such as Western blotting, immunoprecipitation, and immunofluorescence microscopy.
GIN4 antibodies are typically generated through either polyclonal or monoclonal approaches. Based on established protocols, researchers can create anti-GIN4 antibodies by:
Expressing full-length GIN4 or specific domains as fusion proteins (such as with maltose-binding protein or GST)
Purifying the fusion protein from bacterial expression systems
Immunizing rabbits or other host animals with the purified protein
Affinity purifying the resulting antibodies using columns containing immobilized GIN4 protein or fragments
For tagged versions of GIN4, researchers may also generate antibodies against the tag itself, such as HA-tag antibodies for HA-tagged GIN4 constructs. These antibodies can be generated by immunizing rabbits with HA peptides (e.g., CPDYAGYPYDVPDYAG) conjugated to carrier proteins like keyhole limpet hemocyanin .
| Application | Purpose | Key Methodological Considerations |
|---|---|---|
| Western Blotting | Detection of GIN4 expression levels and phosphorylation states | Optimize antibody dilution (typically 1:1000-1:5000); consider phosphatase treatment controls when studying phosphorylation |
| Immunoprecipitation | Isolation of GIN4 and associated protein complexes | Use affinity-purified antibodies bound to protein A beads; include appropriate controls (anti-GST or anti-MBP antibodies) |
| Immunofluorescence | Visualization of GIN4 localization in cells | Fixation method critical; paraformaldehyde typically preferred; include peptide competition controls |
| Kinase Assays | Assessment of GIN4 activity | Immunoprecipitate GIN4 using specific antibodies before performing kinase reactions |
For optimal immunoprecipitation of GIN4 and its associated proteins, the following protocol has been demonstrated to be effective:
Prepare affinity-purified anti-GIN4 antibodies bound to protein A beads (approximately 5 μg of antibody per 20 μl of protein A beads)
Use a lysis buffer containing 50 mM HEPES-KOH (pH 7.6), 175 mM KCl, 75 mM NaF, 1 mM EGTA, 1 mM MgCl₂, 0.45% Tween-20, and 5% glycerol, supplemented with protease inhibitors
Incubate cell lysates with antibody-coupled beads for 1.5-2 hours at 4°C with gentle rotation
Wash the beads multiple times with lysis buffer containing 10% glycerol
Elute GIN4 and associated proteins using high salt conditions (e.g., 1 M KCl)
When studying mitotic complexes, it's advisable to synchronize cells using approaches such as benomyl treatment to arrest cells in mitosis for 2.5 hours before harvesting .
GIN4 antibodies are valuable tools for investigating the Gin4-septin complex formation, which plays a crucial role in cell morphogenesis and cytokinesis. A methodological approach includes:
Immunoprecipitate GIN4 using anti-GIN4 antibodies as described above
Analyze co-precipitating proteins by Western blotting using antibodies against specific septins (e.g., anti-Shs1, anti-Cdc11)
To confirm direct interactions, perform reciprocal immunoprecipitations using septin antibodies
Include controls with non-specific antibodies to ensure specificity of the interactions
Consider using synchronized cell populations, as the Gin4-septin complex is cell cycle-dependent with peak formation during mitosis
Research has demonstrated that Gin4 associates with septin proteins during mitosis as part of a multiprotein complex that includes Nap1, Bni5, and the septins .
When performing Western blotting with GIN4 antibodies, the following controls should be included:
Positive control: Lysate from wild-type cells known to express GIN4
Negative control: Lysate from gin4Δ deletion strains
Specificity control: Preincubation of the antibody with excess purified GIN4 protein (peptide competition)
Loading control: Probing for a housekeeping protein (e.g., actin, GAPDH)
Phosphorylation controls: When studying phosphorylation states, include samples treated with phosphatases
For tagged GIN4 constructs, additional controls should include untransfected cells and cells expressing the tag alone to distinguish GIN4-specific signals from background.
The hyperphosphorylation of GIN4 during mitosis is a critical regulatory event that activates its kinase activity. To investigate this phenomenon using GIN4 antibodies:
Cell synchronization approach:
Arrest cells at different cell cycle stages (e.g., using α-factor for G1, hydroxyurea for S-phase, or benomyl for mitosis)
Harvest cells at different time points after release from arrest
Immunoprecipitate GIN4 using anti-GIN4 antibodies
Analyze phosphorylation by:
Mobility shift in SDS-PAGE
Phospho-specific antibodies if available
Mass spectrometry to identify specific phosphorylation sites
In vitro kinase assays:
Research has shown that GIN4 molecules present in mitotic complexes phosphorylate each other, leading to hyperphosphorylation, which can be detected as mobility shifts in SDS-PAGE analysis .
When using GIN4 antibodies to study protein-protein interactions beyond the known Gin4-septin complex:
Immunoaffinity purification followed by mass spectrometry:
Proximity-dependent labeling:
Fuse GIN4 to a proximity labeling enzyme (BioID or TurboID)
Use GIN4 antibodies to confirm proper expression and localization
Identify labeled proteins as potential interaction partners
Co-immunoprecipitation validation:
For newly identified interactions, perform reverse co-immunoprecipitation
Use appropriate controls to rule out non-specific binding
Consider the impact of detergents on complex stability
| Method | Advantages | Limitations | Key Controls |
|---|---|---|---|
| Standard Co-IP | Preserves native complexes | May miss weak/transient interactions | Anti-GST or anti-MBP antibodies as negative controls |
| Cross-linking Co-IP | Captures transient interactions | May introduce artifacts | No-crosslinker control |
| Immunoaffinity Purification | Higher purity for MS analysis | Requires tagged constructs | Mock purifications from untagged strains |
| Proximity Labeling | Detects spatial proximity in vivo | May identify non-direct interactors | Kinase-dead GIN4 constructs |
To investigate GIN4 kinase activity using GIN4 antibodies:
Immunoprecipitation kinase assays:
Immunoprecipitate GIN4 using anti-GIN4 antibodies
Incubate immunoprecipitates with recombinant substrates (e.g., purified Shs1) and ATP
Detect phosphorylation by:
Autoradiography (using [γ-³²P]ATP)
Phospho-specific antibodies
Mass spectrometry
In-gel kinase assays:
Immunoprecipitate GIN4 and resolve by SDS-PAGE
Renature proteins in the gel
Incubate with kinase reaction buffer containing substrate and [γ-³²P]ATP
Detect activity by autoradiography
Identification of physiological substrates:
Immunoprecipitate GIN4 from wild-type and kinase-dead mutants
Identify differentially phosphorylated proteins by mass spectrometry
Validate with phospho-specific antibodies
Research has demonstrated that the Shs1 septin undergoes GIN4-dependent phosphorylation during mitosis and appears to be a substrate of GIN4 in vitro, suggesting it is a physiological target of GIN4 kinase activity .
Generating phospho-specific GIN4 antibodies requires:
Identification of key phosphorylation sites:
Immunoprecipitate GIN4 from mitotic cells
Analyze by mass spectrometry to identify phosphorylation sites
Select sites with potential regulatory significance
Antibody generation:
Synthesize phosphopeptides corresponding to identified sites
Conjugate to carrier protein
Immunize rabbits or other host animals
Perform dual affinity purification:
First with phosphopeptide column to isolate phospho-reactive antibodies
Then with non-phosphopeptide column to remove antibodies that recognize non-phosphorylated epitopes
Validation approaches:
Western blotting comparing samples from wild-type and kinase-dead mutants
Dephosphorylation controls using lambda phosphatase treatment
Peptide competition assays with phospho and non-phospho peptides
Testing against GIN4 with mutagenized phosphorylation sites
When experiencing weak signals in immunofluorescence experiments with GIN4 antibodies:
Fixation optimization:
Test different fixation methods (paraformaldehyde, methanol, acetone)
Optimize fixation duration and temperature
Consider epitope retrieval methods if the antibody recognizes a conformational epitope
Antibody concentration:
Titrate antibody concentration over a wider range
Consider longer incubation times (overnight at 4°C)
Use signal amplification methods (tyramide signal amplification)
Blocking optimization:
Test different blocking agents (BSA, normal serum, commercial blockers)
Extend blocking time to reduce background
Detection system:
Use high-sensitivity secondary antibodies
Consider conjugated primary antibodies to eliminate secondary antibody variability
Try biotin-streptavidin amplification systems
Sample preparation:
For yeast cells, optimize spheroplasting conditions to improve antibody accessibility
Consider permeabilization optimization with different detergents
Using GIN4 antibodies across different species presents several challenges:
Epitope conservation:
Sequence divergence between orthologs may affect antibody recognition
Perform sequence alignment of GIN4 orthologs to identify conserved regions
Consider generating antibodies against highly conserved domains
Validation strategies:
Use knockout/knockdown controls in each species to confirm specificity
Perform Western blots to verify appropriate molecular weight detection
Consider testing recombinant GIN4 proteins from different species
Cross-reactivity testing:
Test antibodies against related kinases to assess specificity
Perform peptide competition assays with orthologous peptides
Alternative approaches:
When cross-reactivity is poor, consider generating species-specific antibodies
Alternatively, use epitope tagging approaches (HA, FLAG) and corresponding tag antibodies
For model organisms with poor GIN4 antibody recognition, consider using antibodies against conserved interaction partners
Emerging methodologies that can be combined with GIN4 antibodies include:
Super-resolution microscopy:
Use highly specific GIN4 antibodies conjugated to bright fluorophores
Apply techniques like STORM, PALM, or SIM to visualize GIN4 localization at nanoscale resolution
Combine with septin antibodies for co-localization studies beyond diffraction limit
Live-cell imaging approaches:
Generate nanobodies derived from GIN4 antibodies for live-cell applications
Fuse nanobodies to fluorescent proteins for dynamic tracking
Compare fixed-cell antibody staining with live-cell dynamics
Spatial proteomics:
Use GIN4 antibodies for proximity labeling in specific cellular compartments
Combine with mass spectrometry to identify location-specific interaction partners
Compare interactomes across cell cycle stages
Antibody-based biosensors:
Develop FRET-based biosensors incorporating GIN4 antibody fragments
Monitor GIN4 conformational changes or phosphorylation states in real-time
Apply in live-cell imaging to correlate GIN4 activity with cellular events
These advanced methodologies can provide unprecedented insights into GIN4 function, localization, and regulation in both normal and perturbed cellular states.